Recruiting
Early Phase 1

HRG 80

Sponsor:

Practitioners Alliance Network

Code:

NCT04599348

Conditions

Fibromyalgia

CFS

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HRG 80 Red Ginseng

Study Details

Brief summary:

Will a unique form of ginseng be clinically helpful in those with chronic fatigue syndrome and fibromyalgia?

Conditions

Fibromyalgia

CFS

Study ID

NCT04599348

Start date

Oct 14, 2020

Status verified date

Oct, 2020

Completion date

Apr 30, 2021

Anticipated

Primary completion date

Apr 30, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. be diagnosed with CFS and/or fibromyalgia
2. live in the United States 3 - be over 18 years of age

Exclusion Criteria:

  • Pregnancy

Study Design

Enrollment

70 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Active Ginseng treatment

People with CFS or Fibromyalgia will receive HRG 80 Red GInseng

Interventions

HRG 80 Red Ginseng

A unique form of ginseng with the high level of active ginseng components similar to those found in the wild ginseng used in earlier studies.

Primary outcome measure

  • Composite Visual analog scale of symptoms [ Time Frame: 6 weeks ]

Central Contacts and Locations

Central contacts

Jacob Teitelbaum, MD

4105627409FatigueDoc@gmail.com

Locations

Kona Research Center

Recruiting

Kailua, Hawaii, United States, 96740

Contacts

Jacob Teitelbaum

410-562-7409FatigueDoc@gmail.com

More Information

Sponsor

Practitioners Alliance Network

Last update posted

Oct 22, 2020

Last verified

Oct, 2020

Keywords

  • Ginseng

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-11. This information was provided to ClinicalTrials.gov by Practitioners Alliance Network on 2020-10-22.